Richard L. Kravitz, MD, MSPH and Jodi Halpern, MD, PhD
Patients have a responsibility to discerningly present the drug information they receive from direct-to-consumer advertising and to be active partners with their physician in making health care decisions.
Physicians are cautioned that the two obstacles to reforming post-marketing clinical trials are the FDA's reluctance to revisit past approvals and its inability to enforce pharmaceutical companies' commitment to conduct Phase IV trials.
A physicians urges practitioners to use cost-effective alternatives to dispensing samples to patients who cannot afford to pay for their prescriptions.
Physicians are held legally responsible if patients are harmed by not receiving the care that is required, even when the restriction of that care is imposed by a third-party payor.
Physicians should help patients resolve the issue of medical debt by advocating for change in the health care system on a local and national level and implementing charity care within their offices.